Skip to main content

T Cell Lymphoma News

Toxicities Rare After Two Weeks of CAR T-Cell Therapy Infusion

TUESDAY, July 30, 2024 – New-onset cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) are rare beyond two weeks following infusion of CD19-directed...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Non-Hodgkin's Lymphoma